Boeing Win Clarifies Board Oversight Duties Amid Looming Blue Bell Ruling

A Delaware Chancery Court decision dismissed an investor lawsuit against Boeing Co., providing clarity to corporate directors on board supervision of critical risks and operations. The ruling, which found no 'bad faith dereliction of duty upon seeing a red flag' by Boeing's directors, confirms what lawyers advise boards: if you're doing your job, you don't need to lose sleep over worries about something bad happening.

Named for the 1996 In re Caremark Int'l Inc. Derivative Litig. ruling, corporate oversight claims rarely succeed because liability requires sustained or systemic failures. A recent case against Blue Bell Creameries' board, which allegedly failed to make a good-faith effort to monitor mission-critical risks before a fatal listeria outbreak, has been ongoing since 2019.

Boeing's win 'gives directors a little more comfort in the sense that everything is not necessarily going to be under a microscope every time,' said Charles Elson, a retired law professor who served on a Blue Bell special litigation committee. However, he emphasized that directors must exercise vigilance and diligence.